Se Hyun Paek

Dr. Se Hyun Paek

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2022 in Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
Verified
Journal Article
Closed access
SPSe Hyun Paek
Se Hyun Paek
HKHyungju Kwon
Hyungju Kwon
KKKyung Ho Kang
Kyung Ho Kang
Background: We aimed to investigate the potential advantages of bilateral axillo-breast approach (BABA) robotic thyroidectomy over conventional open surgery and to determine whether it is a safe and complete surgical procedure compared with open surgery in patients with papillary thyroid cancer. Patients and Methods: We retrospectively reviewed the records of 315 consecutive patients (robotic, n=54; open, n=261) who underwent total thyroidectomy and central neck dissection for papillary thyroid cancer from March 2013 to June 2014. Postoperative complication rate and surgical completeness were analyzed between patients who underwent BABA robotic thyroidectomy (robotic group) and those who chose open thyroidectomy (open group) after propensity score matching according to age, sex, body mass index, tumor size, extrathyroidal extension, and lymph node (LN) metastasis. Results: Transient hypoparathyroidism was higher in the open group than in the robotic group (13.0% vs. 1.9%; P=0.029). No difference was observed in the mean number of retrieved LNs and metastatic LNs. The mean level of stimulated thyroglobulin was acceptably low in both groups, and there was no difference in the proportion of patients who had stimulated thyroglobulin levels <1 ng/mL between the groups (P=0.543). Conclusions: Our results show that the outcomes of BABA robotic thyroidectomy may be comparable to those of conventional open thyroidectomy, with possibly better preservation of blood supply to the parathyroid glands, without sacrificing surgical completeness.

1 January 2019 in Journal of Breast Cancer
Verified
Journal Article
Open access
SPSe Hyun Paek
Se Hyun Paek
HKHyun Goo Kim
Hyun Goo Kim
JLJun Woo Lee
Jun Woo Lee
JWJoohyun Woo
Joohyun Woo
HKHyungju Kwon
Hyungju Kwon
NPNam-Sun Paik
Nam-Sun Paik
Paek SH, et al. J Breast Cancer. 2018 Dec;22:e15. https://doi.org/10.4048/jbc.2019.22.e15

14 May 2024 in Breast Cancer Research and Treatment
Verified
Journal Article
Open access
PDF file
MLMinah Lee
Minah Lee
JWJoohyun Woo
Joohyun Woo
SPSe Hyun Paek
Se Hyun Paek
HKHyun Goo Kim
Hyun Goo Kim
WLWoosung Lim
Woosung Lim
JLJun Woo Lee
Jun Woo Lee
Purpose: This single-center, randomized, prospective, exploratory clinical trial was conducted to assess the clinical efficacy of an augmented reality (AR)—based breast cancer localization imaging solution for patients with breast cancer. Methods: This clinical trial enrolled 20 women who were diagnosed with invasive breast cancer between the ages of 19 and 80, had a single lesion with a diameter ≥ 5 mm but ≤ 30 mm, had no metastases to other organs, and had not received prior chemotherapy. All patients underwent mammography, ultrasound, computed tomography, and magnetic resonance imaging for preoperative assessment. Patients were randomly assigned to ultrasound-guided skin marking localization (USL) and AR-based localization (ARL) groups (n = 10 in each group). Statistical comparisons between USL and ARL groups were made based on demographics, radiologic features, pathological outcomes, and surgical outcomes using chi-square and Student t-tests. Results: Two surgeons performed breast-conserving surgery on 20 patients. Histopathologic evaluation of all patients confirmed negative margins. Two independent pathologists evaluated the marginal distances, and there were no intergroup differences in the readers' estimates (R1, 6.20 ± 4.37 vs. 5.04 ± 3.47, P = 0.519; R2, 5.10 ± 4.31 vs. 4.10 ± 2.38, P = 0.970) or the readers' average values (5.65 ± 4.19 vs. 4.57 ± 2.84, P = 0.509). In comparing the tumor plane area ratio, there was no statistically significant difference between the two groups in terms of either reader's mean values (R1, 15.90 ± 9.52 vs. 19.38 ± 14.05, P = 0.525; R2, 15.32 ± 9.48 vs. 20.83 ± 12.85, P = 0.290) or the overall mean values of two readers combined (15.56 ± 9.11 vs. 20.09 ± 13.38, P = 0.388). Convenience, safety, satisfaction, and reusability were all superior in the AR localization group (P < 0.001) based on the two surgeons' responses. Conclusion: AR localization is an acceptable alternative to ultrasound-guided skin marking with no significant differences in surgical outcomes.

Verified
Journal Article
Open access
PDF file
SJSeok-Hoon Jang
Seok-Hoon Jang
SPSe Hyun Paek
Se Hyun Paek
JKJong-Kyu Kim
Jong-Kyu Kim
JSJe Kyung Seong
Je Kyung Seong
WLWoosung Lim
Woosung Lim
Hormone receptor-positive breast cancer (HR+ BC) cells depend on estrogen and its receptor, ER. Due to this dependence, endocrine therapy (ET) such as aromatase inhibitor (AI) treatment is now possible. However, ET resistance (ET-R) occurs frequently and is a priority in HR+ BC research. The effects of estrogen have typically been determined under a special culture condition, i.e., phenol red-free media supplemented with dextran-coated charcoal-stripped fetal bovine serum (CS-FBS). However, CS-FBS has some limitations, such as not being fully defined or ordinary. Therefore, we attempted to find new experimental conditions and related mechanisms to improve cellular estrogen responsiveness based on the standard culture medium supplemented with normal FBS and phenol red. The hypothesis of pleiotropic estrogen effects led to the discovery that T47D cells respond well to estrogen under low cell density and medium replacement. These conditions made ET less effective there. The fact that several BC cell culture supernatants reversed these findings implies that housekeeping autocrine factors regulate estrogen and ET responsiveness. Results reproduced in T47D subclone and MCF-7 cells highlight that these phenomena are general among HR+ BC cells. Our findings offer not only new insights into ET-R but also a new experimental model for future ET-R studies.

1 January 2024 in Annals of Robotic and Innovative Surgery
Verified
Journal Article
Open access
PDF file
JKJoo Heung Kim
Joo Heung Kim
SLSae Byul Lee
Sae Byul Lee
HPHyung Seok Park
Hyung Seok Park
KKKu Sang Kim
Ku Sang Kim
JCJung Eun Choi
Jung Eun Choi
YKYoung-Joon Kang
Young-Joon Kang
Kim JH, et al. Ann Robot Innov Surg. 2024 May;5(1):1-9. https://doi.org/10.37007/aris.2024.5.1.1